JP2007506664A5 - - Google Patents

Download PDF

Info

Publication number
JP2007506664A5
JP2007506664A5 JP2006515980A JP2006515980A JP2007506664A5 JP 2007506664 A5 JP2007506664 A5 JP 2007506664A5 JP 2006515980 A JP2006515980 A JP 2006515980A JP 2006515980 A JP2006515980 A JP 2006515980A JP 2007506664 A5 JP2007506664 A5 JP 2007506664A5
Authority
JP
Japan
Prior art keywords
formula
compound
alkyl
optionally
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006515980A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007506664A (ja
Filing date
Publication date
Priority claimed from GBGB0314488.8A external-priority patent/GB0314488D0/en
Application filed filed Critical
Publication of JP2007506664A publication Critical patent/JP2007506664A/ja
Publication of JP2007506664A5 publication Critical patent/JP2007506664A5/ja
Pending legal-status Critical Current

Links

JP2006515980A 2003-06-20 2004-06-16 マトリックスメタロプロテイナーゼの阻害剤 Pending JP2007506664A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0314488.8A GB0314488D0 (en) 2003-06-20 2003-06-20 Therapeutically useful compounds
PCT/EP2004/006553 WO2004113279A1 (en) 2003-06-20 2004-06-16 Inhibitors of matrix metalloproteinase

Publications (2)

Publication Number Publication Date
JP2007506664A JP2007506664A (ja) 2007-03-22
JP2007506664A5 true JP2007506664A5 (enExample) 2007-07-26

Family

ID=27637076

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006515980A Pending JP2007506664A (ja) 2003-06-20 2004-06-16 マトリックスメタロプロテイナーゼの阻害剤

Country Status (5)

Country Link
US (2) US7375248B2 (enExample)
EP (1) EP1636174A1 (enExample)
JP (1) JP2007506664A (enExample)
GB (1) GB0314488D0 (enExample)
WO (1) WO2004113279A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0321538D0 (en) * 2003-09-13 2003-10-15 Glaxo Group Ltd Therapeutically useful compounds
KR101274309B1 (ko) 2005-02-22 2013-06-13 랜박시 래보러터리스 리미티드 천식 및 기타 질병의 치료를 위한 기질 메탈로프로테나제저해제로서 5-페닐-펜탄산 유도체
BRPI0715231A2 (pt) 2006-08-22 2013-06-25 Ranbaxy Lab Ltd compostos, composiÇÕes farmacÊuticas e seus usos, auxiliar quiral e seu uso e processos para preparar um composto
US8389500B2 (en) 2008-10-30 2013-03-05 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
CA2785898C (en) 2009-12-31 2018-07-03 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
JP2013532688A (ja) 2010-07-26 2013-08-19 ブリストル−マイヤーズ スクイブ カンパニー Ｃｙｐ１７阻害剤として有用なスルホンアミド化合物
KR20130042590A (ko) 2010-07-30 2013-04-26 랜박시 래보러터리스 리미티드 기질 메탈로프로테나제 저해제
CN103228634A (zh) * 2010-09-24 2013-07-31 兰贝克赛实验室有限公司 基质金属蛋白酶抑制剂
EP2619179A1 (en) 2010-09-24 2013-07-31 Ranbaxy Laboratories Limited Matrix metalloproteinase inhibitors
WO2014083229A1 (es) 2012-11-28 2014-06-05 Administración General De La Comunidad Autónoma De Euskadi Uso de inhibidores de metaloproteasas en el tratamiento de enfermedades hepáticas poliquísticas

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139626A (en) 1975-05-29 1976-12-02 Sumitomo Chem Co Ltd A herbicide and a process for its preparation
AT368358B (de) * 1977-12-24 1982-10-11 Fisons Ltd Schaedlingsbekaempfungs- und pflanzenwachstumsregulierungsmittel
US5852192A (en) * 1992-03-11 1998-12-22 Dr. Karl Thomae Gmbh Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
US5863949A (en) 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
US5710171A (en) * 1995-05-24 1998-01-20 Merck & Co., Inc. Bisphenyl inhibitors of farnesyl-protein transferase
EP0795550B1 (en) * 1996-03-11 2002-06-05 Sankyo Company Limited Aniline derivatives having herbicidal activity their preparation and their use
ATE207891T1 (de) * 1996-05-17 2001-11-15 Warner Lambert Co Biphenylsulfonamid matrix metalloproteinase inhibitoren
JP2002514179A (ja) * 1996-09-04 2002-05-14 ワーナー―ランバート・コンパニー マトリックスメタロプロテイナーゼの阻害剤としてのビフェニル酪酸およびその誘導体
GB9801690D0 (en) * 1998-01-27 1998-03-25 Pfizer Ltd Therapeutic agents
JPH11236369A (ja) * 1998-02-23 1999-08-31 Kotobuki Seiyaku Kk スルホンアミド誘導体及びその製造法並びにこれを含有する医薬組成物
AU757680B2 (en) * 1999-07-01 2003-02-27 Taisho Pharmaceutical Co., Ltd. Aminobenzoic acid derivatives
US6451832B2 (en) * 1999-12-23 2002-09-17 Boehringer Ingelheim Pharma Kg Benzimidazoles with antithrombotic activity
US6897237B2 (en) * 2000-04-28 2005-05-24 Shionogi & Co. Ltd. MMP-12 inhibitors
JP2002205986A (ja) * 2000-11-08 2002-07-23 Takeda Chem Ind Ltd ピリミジン誘導体およびそれを含有する除草剤
JP2002193800A (ja) 2000-12-22 2002-07-10 Taisho Pharmaceut Co Ltd Ｖｅｇｆ受容体拮抗剤
MXPA03009361A (es) * 2001-04-13 2004-01-29 Boehringer Ingelheim Pharma Compuestos de urea utilies como agentes anti-inflamatorios.
GB0124928D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
WO2003035610A1 (en) * 2001-10-26 2003-05-01 Shionogi & Co., Ltd. Sulfonamide derivative having mmp inhibitory activity

Similar Documents

Publication Publication Date Title
JP2006526590A5 (enExample)
JP2006507265A5 (enExample)
JP2009502743A5 (enExample)
JP2006526031A5 (enExample)
JP2007523139A5 (enExample)
JP2007510619A5 (enExample)
JP2004536811A5 (enExample)
JP2009538336A5 (enExample)
JP2006525365A5 (enExample)
JP2005530811A5 (enExample)
JP2010520214A5 (enExample)
JP2006504738A5 (enExample)
JP2007502817A5 (enExample)
JP2005516898A5 (enExample)
JP2005517008A5 (enExample)
JP2004525178A5 (enExample)
EP1712548A3 (en) 5-amino-4-hydroxy-7-(pyridinylmethyl)-alkanamide derivatives and related compounds as renin inhibitors for the treatment of hypertension
JP2004510750A5 (enExample)
JP2005502636A5 (enExample)
JP2004523478A5 (enExample)
JP2008520662A5 (enExample)
JP2011508779A5 (enExample)
JP2010510263A5 (enExample)
JP2004538278A5 (enExample)
JP2006505567A5 (enExample)